Global Eye Cancer Market Research and Forecast 2018-2023

Posted by Orion Market Research on September 25th, 2018

The eye cancer market is expected to grow significantly during the forecast period (2018-2023). Eye cancer can be described as types of tumors that can occur in various parts of the eye. There are various types of eye cancers such as intraocular cancer, squamous cell cancer, Rhabdomyosarcoma, and Basal cell skin cancer. Some factors that are driving the growth of this sector consist of increasing prevalence of eye cancer across the globe. Government initiatives in the field of Research and Development have reinforced this sector by bringing more and more innovations and improvement in the eye care treatment. With the technological advancement various surgeries and innovative treatments have been introduced for the cure of this disease. Some of the major treatments are eye implant, artificial eyes, enucleation, and tumour resection.

Browse full report at: Global Eye Cancer Market

Rising healthcare expenditure and widen consciousness among people across the globe are creating opportunities for future growth of this sector. However, some of the hurdles consist of high cost of medicines, unavailability of skilled professionals especially in rural areas, and side effect of the treatment. There are cases when even treatments are always not possible. In addition, longer time taken by the ocular cancer drugs to get approved by the authorized body also hampers the growth of the market.

Global eye cancer market can be segmented on the basis of types treatments and end users. According to the types, the market is bifurcated as intraocular cancer and extraocular cancer. Based on the treatment, the market is further subdivided as chemotherapy, surgery and radiation therapy, biologic therapy, hormone therapy and targeted therapy. On the basis of end user, the market is diversified as hospitals and clinics and ambulatory care centres.

Considering the geographical regions North America is expected to dominate the global eye cancer market with its capabilities of advanced technologies which leads to introduction of various innovative treatments, and high healthcare spending. Europe holds the adequate market share due to the presence of opportunities for the development of the market. Asia Pacific region being the fastest developing market of the eye cancer. Asia Pacific market is majorly ruled by the widen population with increasing awareness among them and rising medical facilities.

The major companies contributing to the global eye cancer market includes Novartis International AG, GlaxoSmithKline plc, Bayer AG, Amgen Incorporation, Bristol-Myers Squibb Company, Pfizer Incorporation, Merck & Company Incorporation, OncoMed Pharmaceuticals, Sanofi, AbbVie incorporation, and Eli Lilly and Company. The companies are coming with more and more innovations in the products and their services to enhance the market growth.

For related reports please visit: Healthcare Industry

Like it? Share it!


Orion Market Research

About the Author

Orion Market Research
Joined: June 25th, 2018
Articles Posted: 331

More by this author